SEATTLE, March 16, 2021, (MEDGADGET) — Synthetic biology is extensively used in the medical and pharmaceutical industry for manufacturing of improved biological drugs and system to meet various challenges in the healthcare sector. This process involves the construction and design of new biological systems from standardizing genetic components along with the essential redesign of existing life for new purposes. Synthetic biology offers various opportunities in the field of healthcare such as recreating highly complex pathways, DNA sequences, and natural biological systems.
The global synthetic biology market size is estimated to be valued at US$ 6.09 billion in 2018 and is expected to witness a CAGR of 33.9% during the forecast period (2018–2026).
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/112
Rising funding on research and development coupled with the growing number of synthetic biology are projected to boost market growth.
Increasing funding/investment from manufacturers in the field of synthetic biology offer lucrative growth opportunity to produce such as advanced consumer goods, industrial chemicals, and bioengineered medicines. According to SynBioBeta data finding, January 2018, 50 companies including public and private companies raised over US$ 1.7 billion for the development of innovative synthetic biology technologies. Furthermore, according to the finding, the number of synthetic biology-based companies is growing significantly. According to the same source, in 2013, the total number of synthetic biology companies worldwide were 293, which increased to 346 (2014), 387 (2015), and 411 (2016).
For instance, in December 2017, Ginkgo Bioworks: a biotechnology company working in synthetic biology having an area of interest in cultured ingredients, strain improvement, and enzyme production; invested US$ 275 million in Series D finding to increase its production facility for the organism engineering- Bioworks 3, which was its third foundry for prototyping and scaling engineered organisms.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://bit.ly/2Q4kmf7
Players are also involved in several joint ventures and partnerships with other organizations to increase their market share. For instance, in March 2018, Bayer and Ginkgo Bioworks entered into a joint venture and established a new company— Joyn Bio— with an aim to focus on engineering plant-associated microbes for improved nitrogen fixation.
Furthermore, in July 2018, Poseida Therapeutics Inc. received US$ 3.99 million CLIN 1 grant from the California Institute for Regenerative Medicine (CIRM) to support the late-stage preclinical development of Poseida’s P-PSMA-101, a CAR-T immunotherapy product candidate.
Expanding the application of Synthetic Biology
The synthetic biology delivers high efficiency to re-engineer and design the artificial biomolecular and biomaterial components, which are majorly adopted across biological, industrial and environmental applications such as gene engineering, novel protein synthesis, drug discovery & therapeutics, biofuels, artificial tissue regeneration, industrial enzymes, bioremediation, and green chemicals.
Recently, synthetic biology was tested to be used for the storage of digital data. DNA offers the potential to store the massive amount of digital data, allowing to store one million times more dense information than flash drives, and this data stored in DNA can be preserved for over 1,000 years. At present, it is easy to prevent or detect the attempt to modify the stored data in the DNA and various research and possible attempts are under the process to commercialize this technology. For instance, in September 2018, the Arch Mission Foundation partnered with Microsoft, University of Washington, and Twist Bioscience to archive 10,000 crowdsourced images and full text of 20 important books, among others, in Astrobotic’s 2020 mission to the moon. DNA-based data storage allows data to be encoded into billions of synthetic DNA molecules and encapsulated for long-term preservation.
The biopharmaceutical industry is experiencing challenges such as the faster process of building of drugs pipeline, need for improved productivity, reduce costs, and time to market the product. In this context, custom engineering enzymes through the application of synthetic biology will work as a catalyst in novel and efficient manufacturing processes. Moreover, due to technological advances in genetic engineering and the integration of computational methods has paved the way for the development of highly improved and advanced biocatalyst to improve efficiency and reduce the cost in the discovery, development, and manufacturing of drug products and active pharmaceutical ingredients (APIs).
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/synthetic-biology-market-to-surpass-us-628-billion-threshold-by-2026-92
From the geographical point of view, Asia Pacific is projected to show a promising region for the growth of the synthetic biology market, and this can be credited to the expanding healthcare sector, growing government support, rising concern over fuel consumption and engagement if key players in this region.
For instance, in June 2018, the National Research Foundation (NRF) funded an amount of US$ 25 million for five-year national synthetic biology R&D the program, under the leadership of Prof Chua Nam Hai: a renowned expert in plant biology and biotechnology; to bring advancement in synthetic biology research in Singapore. In September 2018, Thermo Fisher Scientific initiated to sell its portfolio of Invitrogen GeneArt products and services, including gene synthesis and genome editing products in China.
Key players operating in the global synthetic biology market include Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Genscript Biotech Corporation, Codexis, Inc., Amyris, Inc., Danaher Corporation (Integrated DNA Technologies, Inc.), EnBiotix, Inc., Evonetix Ltd., Ginkgo Bioworks, Inc., and Prokarium.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Strategic Collaborations
- Market Dynamics
- Global Synthetic Biology Market, By Product Type, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Oligonucleotides
- Enzymes
- Cloning and Assembly Kits
- Xeno-nucleic Acids (XNA)
- Chassis Organism
- Introduction
- Global Synthetic Biology Market, By Technology, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Gene Synthesis
- Next-generation Sequencing
- Cloning and Sequencing
- Bioinformatics
- Microfluidics
- Nanotechnolog
- Site-saturation Mutagenesis
- Mathematical Modeling
- Introduction
- Global Synthetic Biology Market, By Application, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Medical Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Drug Discovery and Therapeutics
- Artificial Tissue and Tissue Regeneration
- Industrial Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Biomaterials and Green Chemicals
- Industrial Enzymes
- Biofuels and Renewable Energy
- Environmental Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Bioremediation
- Whole-cell Biosensors
- Introduction
- Global Synthetic Biology Market, By Region, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2026
- North America
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Technology, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Section
- References
- Research Methodology
- About Us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837